Shanghai Pharmaceuticals
Shanghai Pharmaceuticals Holding Co., Ltd., commonly referred to as Shanghai Pharmaceuticals, is a leading player in the pharmaceutical industry, headquartered in Shanghai, China. Founded in 1994, the company has established a strong presence in both domestic and international markets, focusing on research and development, manufacturing, and distribution of a wide range of pharmaceutical products.
With a diverse portfolio that includes prescription drugs, over-the-counter medications, and active pharmaceutical ingredients, Shanghai Pharmaceuticals is recognised for its commitment to quality and innovation. The company has achieved significant milestones, including strategic partnerships and expansions into various therapeutic areas, solidifying its position as a key contributor to global healthcare. Notably, Shanghai Pharmaceuticals has been acknowledged for its robust supply chain and extensive distribution network, enhancing its market competitiveness.
-18 vs industry average
Shanghai Pharmaceuticals’s score of 20 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Shanghai Pharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Shanghai Pharmaceuticals yet.
Shanghai Pharmaceuticals's reported carbon emissions
Shanghai Pharmaceuticals, headquartered in CN, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. The company has not outlined any reduction targets or commitments through initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges.
In the absence of specific emissions data, it is important to note that Shanghai Pharmaceuticals is part of an industry increasingly focused on sustainability and reducing carbon footprints. The pharmaceutical sector is under pressure to enhance transparency and accountability regarding climate impacts, and many companies are setting ambitious targets to mitigate their environmental effects.
As Shanghai Pharmaceuticals continues to navigate its climate strategy, stakeholders will be looking for future commitments and initiatives that align with global sustainability goals.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Shanghai Pharmaceuticals’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Shanghai Pharmaceuticals yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Shanghai Pharmaceuticals
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project